Volume 10, Issue 1 (6-2023)                   NBR 2023, 10(1): 17-32 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Niknejad A, Shafizadeh EsfandAbadi A, Abdollahi Sarvestani F. Plant-based vaccines production and conducted experiments in this case, as an effective strategy to combat infectious diseases, such as Coronavirus disease (COVID-19). NBR 2023; 10 (1) :17-32
URL: http://nbr.khu.ac.ir/article-1-3549-en.html
Faculty of Biological Sciences, Kharazmi University, Tehran, Iran , niknejad.azadeh@gmail.com
Abstract:   (1795 Views)
The emergence of new viruses has always been a threat to the health of people around the world, the latest example of it is the new strains of the coronavirus (SARS-CoV-2) and the resulting acute respiratory distress syndrome (ARDS). The current situation underscores the importance of rapidly producing low-cost stable vaccines that do not require refrigeration equipment for storage and transportation. However, most vaccines are not yet available in developing countries due to import costs and storage and transportation needs. Therefore, the vaccine must be affordable for developing countries so that vaccination can be carried out on a large scale. Herbal vaccines are more cost-effective than other types of vaccines and production methods and can be produced in large quantities. In addition, herbal vaccines have other benefits that are discussed in this article. However, given that an herbal medicinal product is to be used as a vaccine in a semi-processed form (such as mashed potatoes or tomato paste), specific regulatory reviews must apply to injectable vaccines. Products should also be applied to evaluate their side effects clinically. The current review article investigates the opportunities and challenges of producing plant-based vaccines to deal with diseases like Coronavirus disease (COVID-19(.


 
Full-Text [PDF 1983 kb]   (453 Downloads)    
Type of Study: Review | Subject: Biotechnology
Received: 2022/06/5 | Revised: 2023/06/1 | Accepted: 2023/01/7 | Published: 2023/06/20 | ePublished: 2023/06/20

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



© 2024 CC BY-NC 4.0 | Nova Biologica Reperta

Designed & Developed by : Yektaweb